181 related articles for article (PubMed ID: 25699085)
21. The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia.
Haro JM; Kamath SA; Ochoa S; Novick D; Rele K; Fargas A; Rodríguez MJ; Rele R; Orta J; Kharbeng A; Araya S; Gervin M; Alonso J; Mavreas V; Lavrentzou E; Liontos N; Gregor K; Jones PB;
Acta Psychiatr Scand Suppl; 2003; (416):16-23. PubMed ID: 12755850
[TBL] [Abstract][Full Text] [Related]
22. The concurrent and predictive validity of symptomatic remission criteria in first-episode schizophrenia.
Chang WC; Chan TC; Chen ES; Hui CL; Wong GH; Chan SK; Lee EH; Chen EY
Schizophr Res; 2013 Jan; 143(1):107-15. PubMed ID: 23151398
[TBL] [Abstract][Full Text] [Related]
23. Clinical global impression of cognition in schizophrenia (CGI-CogS): reliability and validity of a co-primary measure of cognition.
Ventura J; Cienfuegos A; Boxer O; Bilder R
Schizophr Res; 2008 Nov; 106(1):59-69. PubMed ID: 17900866
[TBL] [Abstract][Full Text] [Related]
24. Disparity between General Symptom Relief and Remission Criteria in the Positive and Negative Syndrome Scale (PANSS): A Post-treatment Bifactor Item Response Theory Model.
Anderson AE; Reise SP; Marder SR; Mansolf M; Han C; Bilder RM
Innov Clin Neurosci; 2017 Dec; 14(11-12):41-53. PubMed ID: 29410936
[No Abstract] [Full Text] [Related]
25. To what extent do the PANSS and CGI-S overlap?
Rabinowitz J; Mehnert A; Eerdekens M
J Clin Psychopharmacol; 2006 Jun; 26(3):303-7. PubMed ID: 16702895
[TBL] [Abstract][Full Text] [Related]
26. Psychometric properties of a Spanish-version of the Schizophrenia Objective Functioning Instrument (Sp-SOFI).
Al-Halabí S; Sáiz PA; Garrido M; Galván G; Casares MJ; Bobes-Bascarán MT; Díaz-Mesa EM; Burón P; García-Álvarez L; Suárez-Álvarez J; Muñiz J; García-Portilla MP; Bobes J
Int J Clin Health Psychol; 2016; 16(1):58-75. PubMed ID: 30487851
[TBL] [Abstract][Full Text] [Related]
27. Symptom rating scales and outcome in schizophrenia.
Mortimer AM
Br J Psychiatry Suppl; 2007 Aug; 50():s7-14. PubMed ID: 18019038
[TBL] [Abstract][Full Text] [Related]
28. Changes in memory performance over a 12-month period in relation to achieving symptomatic remission after a first-episode psychosis.
Benoit A; Bodnar M; Malla AK; Joober R; Bherer L; Lepage M
Schizophr Res; 2014 Mar; 153(1-3):103-8. PubMed ID: 24512651
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of paliperidone ER in patients with unsatisfactorily controlled schizophrenia by other antipsychotics: a flexible-dose approach.
Mauri M; Mauri MC; Adami M; Reggiardo G; Giulio C
Int Clin Psychopharmacol; 2015 Nov; 30(6):329-37. PubMed ID: 26230269
[TBL] [Abstract][Full Text] [Related]
30. Treatment of acute schizophrenia with paliperidone ER: predictors for treatment response and benzodiazepine use.
Heres S; Don L; Herceg M; Bidzan L; Blanc M; Siracusano A; Maciulis V; Lahaye M; Schreiner A
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():207-12. PubMed ID: 24096139
[TBL] [Abstract][Full Text] [Related]
31. Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia.
Suzuki T; Uchida H; Sakurai H; Ishizuki T; Tsunoda K; Takeuchi H; Mimura M
Psychiatry Res; 2015 Jun; 227(2-3):265-9. PubMed ID: 25882098
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
[TBL] [Abstract][Full Text] [Related]
33. Predictors of symptomatic remission in patients with first-episode schizophrenia: a 16years follow-up study.
Marchesi C; Affaticati A; Monici A; De Panfilis C; Ossola P; Tonna M
Compr Psychiatry; 2014 May; 55(4):778-84. PubMed ID: 24461689
[TBL] [Abstract][Full Text] [Related]
34. Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.
Novick D; Haro JM; Suarez D; Lambert M; Lépine JP; Naber D
Psychopharmacology (Berl); 2007 May; 191(4):1015-22. PubMed ID: 17310386
[TBL] [Abstract][Full Text] [Related]
35. Psychopharmacotherapy and remission of patients with schizophrenia.
Degmecić D; Pozgain I; Filaković P; Dodig-Curković K; Mihanović M
Coll Antropol; 2009 Jun; 33(2):547-51. PubMed ID: 19662777
[TBL] [Abstract][Full Text] [Related]
36. Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression.
Turkoz I; Fu DJ; Bossie CA; Sheehan JJ; Alphs L
J Affect Disord; 2013 Aug; 150(1):17-22. PubMed ID: 23517884
[TBL] [Abstract][Full Text] [Related]
37. One-year functional outcomes of naturalistically treated patients with schizophrenia.
Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
Addington DE; Pantelis C; Dineen M; Benattia I; Romano SJ
J Clin Psychiatry; 2004 Dec; 65(12):1624-33. PubMed ID: 15641867
[TBL] [Abstract][Full Text] [Related]
39. Long-term effectiveness of flexibly dosed paliperidone extended-release: comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents.
Kim EY; Chang SM; Shim JC; Joo EJ; Kim JJ; Kim YS; Ahn YM
Curr Med Res Opin; 2013 Oct; 29(10):1231-40. PubMed ID: 23777311
[TBL] [Abstract][Full Text] [Related]
40. To a broader concept of remission: rating the health-related quality of life in bipolar disorder.
Subero MM; Berk L; Dodd S; Kulkarni J; De Castella A; Fitzgerald PB; Berk M
J Affect Disord; 2013 Sep; 150(2):673-6. PubMed ID: 23664566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
